AxoGen (AXGN) Tops Q2 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.38 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance
• Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance